CSL Bulk Human Coagulation Factor VIII 500 IU (50 IU/mL) / von Willebrand factor 1200 IU powder for injection vial
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
26-11-2017
अनुरोध भेजा।
सक्रिय संघटक:
Von willebrand factor, Quantity: 1200 IU; Factor VIII, Quantity: 500 IU
थमां उपलब्ध:
CSL Behring Australia Pty Ltd
INN (इंटरनेशनल नाम):
Factor VIII,Von willebrand factor
फार्मास्यूटिकल फॉर्म:
Injection, powder for
रचना:
Excipient Ingredients: sodium citrate dihydrate; trometamol; calcium chloride dihydrate; Albumin; sucrose; sodium chloride
प्रशासन का मार्ग:
Intravenous
चिकित्सीय संकेत:
von Willebrand disease (VWD) - Treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with VWD, when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Haemophilia A (congenital FVIII deficiency) - Prophylaxis and treatment of bleeding in patients with haemophilia A.
उत्पाद समीक्षा:
Visual Identification: A white or pale yellow, hygroscopic powder or friable solid; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
प्राधिकरण का दर्जा:
Licence status A
प्राधिकरण की तारीख:
2013-09-02
